Author： Accardo Antonella Mansi Rosalba Salzano Giuseppina Morisco Anna Aurilio Michela Parisi Antonio Maione Francesco Cicala Carla Ziaco Barbara Tesauro Diego Aloj Luigi De Rosa Giuseppe Morelli Giancarlo
Publisher： Informa Healthcare
ISSN： 1061-186X
Source： Journal of Drug Targeting, Vol.21, Iss.3, 2013-04, pp. : 240-249
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Liposomal doxorubicin effective for advanced breast cancer
Inpharma, Vol. 1, Iss. 1460, 2004-01 ,pp. :
Access to resources
Recommend
Liposomal doxorubicin vs epirubicin in breast cancer
Inpharma, Vol. 1, Iss. 1462, 2004-01 ,pp. :
Targeted Liposomal Drug Delivery in Cancer
Current Pharmaceutical Design, Vol. 10, Iss. 24, 2004-09 ,pp. :
By Schwartsmann G. DiLeone L. Horowitz M. Schunemann D. Cancella A. Pereira A. Richter M. Souza F. Rocha A. Souza F. Pohlmann P. Nucci G.
Investigational New Drugs, Vol. 24, Iss. 5, 2006-09 ,pp. :
Doxorubicin liposomal in ovarian cancer guidance issued by UK NICE
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 374, 2002-01 ,pp. :